| For: | Zhao YR, Wang XJ, Zhu MJ, Chen AL, Zhang D, Du Q, Kim JJ, Hu WL. Efficacy and safety of low-dose tetracycline, amoxicillin quadruple therapy in Helicobacter pylori infection: A retrospective single center study. World J Gastroenterol 2024; 30(39): 4295-4304 [PMID: 39492823 DOI: 10.3748/wjg.v30.i39.4295] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i39/4295.htm |
| Number | Citing Articles |
| 1 |
Barathan Muttiah, Wathiqah Wahid, Asif Sukri, Alfizah Hanafiah. Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance. International Journal of Molecular Sciences 2025; 26(13): 6064 doi: 10.3390/ijms26136064
|
| 2 |
András Gelley, Noémi Kéri, Péter Birinyi, Kinga Komka, Vajk Hardy, László Döngölő, Dóra Szeli, Ibolya Czegle. Optimizing the Routine Use of Clinical Guidelines by Addition of Supplements (Probiotics and/or Bismuth) to Helicobacter pylori Eradication Protocols in a Clarithromycin Resistant and Tetracycline/Bismuth Naive Area: A Real-World Data Retrospective Analysis of 402 Cases (2016–24) in a Single Gastroenterology Unit. Antibiotics 2025; 14(9): 870 doi: 10.3390/antibiotics14090870
|
| 3 |
Jiachen Jing, Jinling Yu, Beina Ji, Jing Guo, Chenlu Li, Zhonghua Cheng. Effects of rebamipide quadruple therapy with gastrointestinal endoscopy adjuvant therapy on gastrointestinal hormones in patients with gastric ulcer bleeding. Arab Journal of Gastroenterology 2025; 26(4): 432 doi: 10.1016/j.ajg.2025.09.013
|
| 4 |
Adrian Bakiera, Anita Solarz, Marika Kowalczyk, Halina Cichoż-Lach, Izabela Korona-Głowniak. Challenges and Prospects for Eradication of Helicobacter pylori: Targeting Virulence Factors, Metabolism, and Vaccine Innovation. Pathogens 2025; 14(7): 619 doi: 10.3390/pathogens14070619
|
